Posts by: Maureen Newman

Maureen Newman

Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.

May 31, 2015

Two Novel Molecules Involved in Prostate Cancer Progression

News

Recent findings at the University of Pittsburgh School of Medicine are unraveling how RNA molecules influence prostate cancer progression. Bino John, PhD, an adjunct professor at Pittsburgh School of Medicine, ... Read more

May 22, 2015May 22, 2015

New Research Focuses on Prostate Cancer Metastasis

News

Prostate cancer that metastasizes to the bone may be curable in the future using new research from the Pharmacology Department at Indiana University School of Medicine. Theresa A. Guise, MD, ... Read more

February 26, 2015February 26, 2015

Researchers Develop Simple Prostate Cancer Assays for ERG

News

In terms of early prostate cancer detection methods, more is better. Researchers at Pacific Northwest National Laboratory in Richland, Washington determined that the ETS-related gene (ERG) is a reliable biomarker for ... Read more

January 12, 2015January 12, 2015

MRI Detection for Prostate Cancer Improved at UCSD

News

In an effort to help detect prostate cancer in men, a team of researchers at University of California, San Diego School of Medicine and University of California, San Diego is ... Read more

December 16, 2014December 16, 2014

BAZ2A Biomarker Predicts Prostate Cancer Malignancy

News

Findings from the “Early Onset Prostate Cancer” project, conducted by a collaboration among the German Cancer Research Center, the University of Zurich, Hamburg-Eppendorf University Hospital, Heidelberg University, and many others, ... Read more

December 8, 2014December 8, 2014

Prostate Cancer Is Not a Side Effect of Testosterone Therapy

News

Testosterone, a hormone given to men with hypogonadism, does not appear to increase the risk of prostate cancer, despite concerns in the scientific community. Ahmad Haider, MD, PhD, a urologist ... Read more

December 5, 2014December 5, 2014

Aggressive Prostate Cancer Treatment Despite Guidelines

News

When men are diagnosed with prostate cancer and have a life expectancy of less than 10 years, national guidelines recommend “watchful waiting” instead of treatment, as patients are unlikely to ... Read more

December 2, 2014December 2, 2014

Prostate Cancer Bone Metastases Blocked with HIV Drug in Mice

News

Lethal bone metastases derived from prostate cancer may be readily prevented with a drug approved to treat HIV, according to new research from the laboratory of Richard Pestell, MD, PhD, ... Read more

November 20, 2014November 20, 2014

Walnuts Slow Prostate Cancer Growth in Mice

News

In the spirit of the season, Paul Davis, PhD, of the University of California, Davis, and colleagues in the laboratory discovered that whole walnuts or walnut oil may slow prostate ... Read more

November 17, 2014November 17, 2014

Killing More Cancerous Cells than Healthy at Thomas Jefferson University

News

Research in the laboratory of Ulrich Rodeck, MD, PhD, at Thomas Jefferson University, is looking to make prostate cancer (and other cancer types) radiation therapy safer and more effective for ... Read more